Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women
Cancer Research UK · University of Oxford
Abstract
Obesity is associated with increased breast cancer risk among postmenopausal women. We examined whether this association could be explained by the relationship of body mass index (BMI) with serum sex hormone concentrations.
We analyzed individual data from eight prospective studies of postmenopausal women. Data on BMI and prediagnostic estradiol levels were available for 624 case subjects and 1669 control subjects; data on the other sex hormones were available for fewer subjects. The relative risks (RRs) with 95% confidence intervals (CIs) of breast cancer associated with increasing BMI were estimated by conditional logistic regression on case-control sets, matched within each study for age and recruitment date, and adjusted for parity. All statistical tests were two-sided.
Citation impact
- FWCI
- 21.37
- Percentile
- 100%
- References
- 28
Authors
1- EHEndogenous Hormones Breast Cancer Collaborative GroupCorresponding
Cancer Research UK, University of Oxford
Topics & keywords
- Estrone
- Dehydroepiandrosterone sulfate
- Breast cancer
- Sex hormone-binding globulin
- Body mass index
- Medicine
- Internal medicine
- Estrone sulfate
- Good health and well-being
Funding
- BABrigham and Women's Hospital
- UOUniversity of Southern California
- UOUniversity of Missouri
- UOUniversity of Connecticut
- JHJohns Hopkins University
- UOUniversity of Pittsburgh
- KUKagoshima University
- YUYork University
- UOUniversity of Oxford
- SOSchool of Medicine, New York University
- UOUniversity of California, San Francisco
- UAUniversity at Buffalo
- NCNational Cancer Institute
- DODivision of Cancer Epidemiology and Genetics, National Cancer Institute